Humanetics.

Other News To Note.
BIOWORLD Today; 11/3/2009; 1688 words; ...P- and L-selectins. Data were presented at the International Symposium of Glycoconjugates in Cairns, Australia. o Humanetics Corp., of Minneapolis, said the FDA granted orphan drug designation to its BIO 300 investigational drug for the prevention...

Pipeline: highlights of progress in drug development.
Nurse Practitioners' Prescribing Reference; 9/22/2009; 995 words; ...promoting agent being reviewed to treat excessive sleepiness associated with jet lag disorder--sNDA submitted NIC5-15 (from Humanetics) a gamma-secretase inhibitor being investigated for the treatment of Alzheimer's disease--Phase 2a Serdaxin (from...

Pipeline: highlights of progress in drug development.(Humanetics)(Rexahn)(briefs)
Physician Assistants' Prescribing Reference; 9/22/2009; 1166 words; ...promoting agent being reviewed to treat excessive sleepiness associated with jet lag disorder--sNDA submitted NIC5-15 (from Humanetics) a gammasecretase inhibitor being investigated for the treatment of Alzheimer's disease--Phase 2a Serdaxin (from Rexahn...

Safety and Cognitive Stability Are Key Findings in Phase IIA Trial of New Alzheimer's Disease Treatment from Humanetics Corporation.
Clinical Trials Week; 7/27/2009; 1579 words; ...suggest that a new Alzheimer's drug from Humanetics Corporation is safe for daily use and...Phase IIB clinical trial (see also Humanetics Corporation). Phase IIA clinical findings...sponsored by Minneapolis, MN-based Humanetics Corporation which also has exclusive...

Mount Sinai Presents Trial Findings at 2009 Alzheimer's Association International Conference
Wireless News; 7/15/2009; 687 words; ...suggest that a new Alzheimer's drug from Humanetics Corp. is safe for daily use and that...sponsored by Minneapolis, MN-based Humanetics Corp. which also has exclusive rights...Sinai School of Medicine has provided to Humanetics certain intellectual property rights...